Thiopental-induced apoptosis in lymphocytes is independent of CD95 activation by Keel, M et al.
University of Zurich





Thiopental-induced apoptosis in lymphocytes is independent of
CD95 activation
Keel, M; Mica, L; Stover, J; Stocker, R; Trentz, O; Härter, L
Keel, M; Mica, L; Stover, J; Stocker, R; Trentz, O; Härter, L (2005). Thiopental-induced apoptosis in lymphocytes
is independent of CD95 activation. Anesthesiology, 103(3):576-584.
Postprint available at:
http://www.zora.uzh.ch




Keel, M; Mica, L; Stover, J; Stocker, R; Trentz, O; Härter, L (2005). Thiopental-induced apoptosis in lymphocytes
is independent of CD95 activation. Anesthesiology, 103(3):576-584.
Postprint available at:
http://www.zora.uzh.ch




Thiopental-induced apoptosis in lymphocytes is independent of
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Abstract
BACKGROUND: Barbiturate coma is used in patients with traumatic brain injury whenever increases
in intracranial pressure remain unresponsive to less aggressive therapeutic regimens. However,
barbiturate-mediated neuroprotection correlates with lymphopenia, which increases the risk of infection.
The mechanisms by which barbiturates lead to lymphopenia remain to be determined. METHODS:
Freshly isolated human lymphocytes and Jurkat cells were incubated with the barbiturate thiopental for
24 and 48 h. Apoptosis was measured by fluorescein isothiocyanate-Annexin and propidium iodide
staining, rhodamine 123 staining, and the terminal deoxynucleotidyl transferase-mediated dUTP nick
end labeling method. Caspase-3 activity was detected by Western blot and substrate cleavage assay.
RESULTS: Thiopental dose-dependently (5-500 microg/ml) increased apoptosis in Jurkat cells from
basal levels (4.4 +/- 1.9%) to 29.7 +/- 2.8% after 24 h and 39.7 +/- 3.2% after 48 h, whereas in
lymphocytes, thiopental-induced necrosis was observed. Parallel to apoptosis, thiopental
dose-dependently increased caspase-3-like activity in Jurkat cells. However, the pan-caspase inhibitor
z-VAD-fmk (20 microm) only marginally reduced thiopental-induced (250 microg/ml) apoptosis in
Jurkat cells (20.2 +/- 2.5 to 17.2 +/- 2.5%) and necrosis in lymphocytes (39.2 +/- 7.5 to 30.7 +/- 14%).
In contrast, anti-CD95-induced apoptosis in Jurkat cells (27.0 +/- 2.0%) was completely blocked by
z-VAD-fmk (8.1 +/- 1.8%). Neither expression of CD95 on Jurkat cells nor pretreatment with a
neutralizing anti-CD95 antibody influenced thiopental-induced apoptosis, indicating that thiopental
induces apoptosis independently of the CD95 system. The nuclear factor kappaB inhibitor gliotoxin
accelerated both thiopental- and CD95-mediated apoptosis, indicating a mutual control mechanism of
thiopental- and CD95-induced apoptosis. CONCLUSIONS: Thiopental directly induces cell death in
lymphocytes and Jurkat cells by a CD95-independent mechanism.
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Thiopental-induced Apoptosis in Lymphocytes Is
Independent of CD95 Activation
Marius Keel, M.D.,* Ladislav Mica, M.D.,† John Stover, M.D.,‡ Reto Stocker, M.D.,§ Otmar Trentz, M.D.,
Luc Ha¨rter, Ph.D.#
Background: Barbiturate coma is used in patients with trau-
matic brain injury whenever increases in intracranial pressure
remain unresponsive to less aggressive therapeutic regimens.
However, barbiturate-mediated neuroprotection correlates with
lymphopenia, which increases the risk of infection. The mech-
anisms by which barbiturates lead to lymphopenia remain to be
determined.
Methods: Freshly isolated human lymphocytes and Jurkat
cells were incubated with the barbiturate thiopental for 24 and
48 h. Apoptosis was measured by fluorescein isothiocyanate–
Annexin and propidium iodide staining, rhodamine 123 stain-
ing, and the terminal deoxynucleotidyl transferase–mediated
dUTP nick end labeling method. Caspase-3 activity was detected
by Western blot and substrate cleavage assay.
Results: Thiopental dose-dependently (5–500 g/ml) in-
creased apoptosis in Jurkat cells from basal levels (4.4  1.9%)
to 29.7  2.8% after 24 h and 39.7  3.2% after 48 h, whereas in
lymphocytes, thiopental-induced necrosis was observed. Paral-
lel to apoptosis, thiopental dose-dependently increased
caspase-3–like activity in Jurkat cells. However, the pan-caspase
inhibitor z-VAD-fmk (20 M) only marginally reduced thiopen-
tal-induced (250 g/ml) apoptosis in Jurkat cells (20.2  2.5 to
17.2  2.5%) and necrosis in lymphocytes (39.2  7.5 to 30.7 
14%). In contrast, anti-CD95–induced apoptosis in Jurkat cells
(27.0  2.0%) was completely blocked by z-VAD-fmk (8.1 
1.8%). Neither expression of CD95 on Jurkat cells nor pretreat-
ment with a neutralizing anti-CD95 antibody influenced thio-
pental-induced apoptosis, indicating that thiopental induces ap-
optosis independently of the CD95 system. The nuclear factor
B inhibitor gliotoxin accelerated both thiopental- and CD95-
mediated apoptosis, indicating a mutual control mechanism of
thiopental- and CD95-induced apoptosis.
Conclusions: Thiopental directly induces cell death in lym-
phocytes and Jurkat cells by a CD95-independent mechanism.
TRAUMATIC brain injury is the leading cause of death in
injured patients,1,2 mostly through cerebral edema and
secondary brain injury.3–6 Brain damage due to the in-
creased intracranial pressure (ICP) can be avoided by
applying different clinical strategies, such as controlled
hyperventilation, mild hypothermia,7 and release of ce-
rebrospinal fluid. In cases of increased ICP exceeding 30
mmHg, which was refractory to the therapeutic inter-
vention, intravenous administration of barbiturate (“bar-
biturate coma”) may become necessary. The beneficial
effect of barbiturates in terms of decreasing increased
ICP is thought to be due to decreased cerebral metabo-
lism and blood flow.8,9 However, this therapy is often
complicated by disturbed immunocompetence with re-
duction of lymphocytes followed by an increased infec-
tion rate.10–12 Lymphocytes are key players of the spe-
cific immune defense system and contribute to the
immune response by cytokine release and activation of
other immune cells. During homeostasis, the number of
lymphocytes in the circulation and tissue is maintained
at an equilibrium by the controlled cell death program,
i.e., apoptosis.13 However the depressed activation of
lymphocytes in patients under barbiturate treatment
contributes to immunosuppression and increase of in-
fections.14
Apoptosis is a highly regulated mechanism involving
several extracellular and intracellular factors.13,15–17
Binding of the soluble CD95 ligand to its plasma mem-
brane receptor CD95 induces apoptosis and represents
the best studied programmed cell death pathway in
T-cell lymphocytes.18,19 Besides the CD95 system, differ-
ent drugs are also able to induce T-cell apoptosis, de-
pending partially on the CD95 pathway.20,21 Moreover,
modulation of apoptosis by cytokines such as interleukin
2 or interferon  has also been shown in T cells.22 In
addition to the CD95 system, a group of intracellular
proteases, called caspases, plays a prominent role in the
regulation and execution of apoptosis.16,23 Among the
various caspases, caspase-3 is considered the major exe-
cutioner of apoptosis, which cleaves several intracellular
structural and cell-cycle–regulating proteins such as
poly(adenosine diphosphate–ribose)polymerase.23 How-
ever, in recent years, evidence has accumulated showing
alternative, e.g., caspase-independent forms of cell death
in lymphocytes.24
We have shown the serum concentrations of thiopen-
tal in patients undergoing thiopental treatment before.25
In this study, the effect of thiopental on lymphocyte
survival was investigated using freshly isolated human
lymphocytes from healthy volunteers or the human leu-
kemic T-cell line Jurkat.
Recently, Loop et al.26 have shown that thiopental
inhibits the activation of nuclear factor B (NF-B) in
Jurkat cells. NF-B is a member of the rel-gen family of
transcription factors and is thought to be involved in
mediating cell survival but also regulates the transcrip-
tion of genes involved in inflammatory and acute stress
responses.27 Here we show that thiopental induces ap-
optosis/necrosis and caspase-3 activation in lymphocytes
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by mechanisms independent of the CD95 system, possi-
bly through inhibition of NF-B.
Materials and Methods
Special Reagents
The following reagents were obtained from commer-
cial sources: propidium iodine (PI) and gliotoxin (Sigma
Chemical Co., St. Louis, MO); Annexin-V–fluorescein iso-
thiocyanate (FITC), terminal deoxynucleotidyl trans-
ferase–mediated dUTP nick end labeling (TUNEL) kit
(Boehringer-Mannheim, Mannheim, Germany), pan-
caspase inhibitor z-VAD-fmk16 (Bachem AG, Bubendorf,
Switzerland); caspase-3 fluorogenic substrate z-DEVD-afc
and rhodamine 123 (Molecular Probes, Inc. Eugene,
OR); agonistic anti-CD95 antibody (CH11; Immunotech,
Coulter, Marseille, France); antagonistic anti-CD95 anti-
body (SM 1/23; Alexis, Grunberg, Germany); FITC-la-
beled anti-CD3 antibody (UCHT1; R&D Systems, Wies-
baden-Nordenstadt, Germany); phycoerythrin-labeled
anti-CD95 antibody (33455X; Becton Dickinson, Basel,
Switzerland); and thiopental (Pentothal, Lot. No.
57879TF; Abbott AG, Baar, Switzerland).
Human Lymphocytes
Human lymphocytes were isolated after Ficoll density
centrifugation of peripheral venous blood from healthy
volunteers. The interface containing monocytes and lym-
phocytes was washed twice and resuspended in medium
RPMI-1640 (Gibco BRL, Life Technologies, Paisley,
United Kingdom) supplemented with 10% fetal calf se-
rum (Gibco BRL) and L-Glutamax (Gibco BRL). After 2 h
of incubation in 24-well cell culture plates (Costar Co.,
Cambridge, MA) at 37°C in a humidified atmosphere (5%
CO2), nonadherent cells ( 95% lymphocytes) were
collected, washed, and resuspended in the same me-
dium at a density of 1  106/ml. Purity was measured by
flow cytometry (FACS Calibur; Becton Dickinson) after
staining with an FITC-CD3 antibody and was found to be
greater than 95%.
Jurkat Cells
Jurkat T cells (106 cells/ml) were maintained in RPMI-
1640 supplemented with 10% fetal calf serum (Gibco
BRL) and 1.5 mM L-Glutamax in 24-well cell culture
plates (Costar Co.) at 37°C in a humidified atmosphere
(5% CO2).
Experimental Protocol
Cells were preincubated for 1 h with or without an-
tagonistic anti-CD95 (SM 1/23) antibody (500 ng/ml),
z-VAD-fmk (20 M), or gliotoxin (0.001–0.01 g/ml)
before stimulation with or without various concentra-
tions of thiopental (5–500 g/ml) or agonistic anti-CD95
(CH11) antibody (20 or 100 ng/ml) for times indicated.
The cell loss in Jurkat cultures was less than 5%, irre-
spective of the experimental design or the added pro-
teins using trypan blue exclusion and microscopic cell
counting.
Cytofluorometric Measurement of Apoptosis and
Necrosis
Determination of apoptosis and secondary necrosis
uses the high affinity of Annexin-V for phosphatidylser-
ine, which is exposed on the cell surface of apoptotic
cells, and of PI to DNA strands.28 Jurkat cells (1 
106/ml) were washed with phosphate-buffered saline,
resuspended in binding buffer (10 mM HEPES–NaOH, pH
7.4, 140 mM NaCl, 2.5 mM CaCl2) and incubated with
0.25 mg/ml FITC–Annexin-V and 50 g/ml PI. The mix-
ture was kept on ice for 5 min, and cell fluorescence was
measured by two-parameter flow cytometry (FACS Cali-
bur).28 When green fluorescence (FITC) was plotted
against red fluorescence (PI) in a dot plot, three distinct
cell populations could be detected: viable cells (FITC
negative, PI negative), apoptotic cells (FITC positive, PI
negative), and secondary necrotic cells (FITC positive, PI
positive). A minimum of 10,000 events (within a gate in
the forward and side scatter window) was counted per
sample, and data were reported as the percentage of
apoptotic cells (Annexin-V–FITC positive, PI negative)
and secondary necrotic cells (Annexin-V–FITC positive,
PI positive).28
Detection of Apoptosis by TUNEL Staining of
Cytospin Slides
For the detection of apoptosis after the experiment,
cytospin preparations of freshly isolated human lympho-
cytes or Jurkat cells (1  105) were treated with a
commercially available kit for the TUNEL technique
(Boehringer Mannheim)29 according to the manufactur-
er’s guidelines. Briefly, air-dried cytospin preparations
were fixed with 4% paraformaldehyde solution, rinsed
with phosphate-buffered saline, and incubated in perme-
abilization solution (0.1% Triton X-100 in 0.1% sodium
citrate) for 5 min on ice. The slides were rinsed again
with phosphate-buffered saline and incubated with
TUNEL reaction mixture (terminal deoxynucleotidyl
transferase, FITC-labeled nucleotides) for 1 h in a humid-
ified chamber. The slides were mounted in 50% glycer-
ol–phosphate-buffered saline and examined on a fluores-
cence microscope (Leica Dialux 22 EB; Leica, Wetzlar,
Germany). Bright homogeneously FITC-stained nuclei
were considered as typical apoptotic features.29 Up to
500 cells were counted per slide. Data are reported as
the percentage of apoptotic cells of all cells stained with
4,6-diamidino-2-phenylindole following standard protocol.
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Detection of Mitochondrial Membrane Breakdown
in Jurkat Cells
Apoptosis of mitochondria was measured in Jurkat
cells (1  106/ml) stained with rhodamine 123 (0.2 M)
for 1 h at 37°C. After a washing step, fluorescence was
measured in the cytometer (FACS Calibur). The mito-
chondrial membrane breakdown in the cells is repre-
sented by a shift of mean fluorescence to the left (de-
crease in channel number). Data are given as percent of
shifted cells from 10,000 cells measured within a for-
ward and side scatter gate.
Analysis of CD95 Expression on Jurkat Cells
Expression of CD95 on Jurkat cells was measured by
flow cytometry (FACS Calibur) with a phycoerythrin–
anti-human-CD95 (33455X) antibody. After 24 h incuba-
tion Jurkat cells (106/ml) were stained with 0.25 mg/ml
phycoerythrin-labeled anti-CD95 antibody for 1 h on ice
before fluorescence was measured in FACS. A minimum
of 10,000 events was counted per sample, and data were
reported as the mean channel fluorescence.
Caspase-3–like Activity Measurement and Western
Blot
Caspase-3–like activity was measured in cellular ex-
tracts from Jurkat cell samples. After incubation, cells
were lysed by freeze–thaw procedure in hypotonic ex-
traction buffer (25 mM HEPES, pH 7.5, 5 mM MgCl2, 0.1%
Triton-X 100, 1 mM Pefablock® with addition of pepsta-
tin, leupeptin, and aprotinin [1 g/ml each]) and subse-
quently centrifuged (15 min, 14,000g, 4°C), and the
supernatant was stored at 80°C until further used. The
fluorometric cleavage assay for caspase-3-like activity
(DEVD-afc; Calbiochem, Nottingham, United Kingdom)
was performed in microtiter plates (Greiner, Nuertin-
gen, Germany) according to the method described by
Thornberry23,30 using the fluorometric plate reader Vic-
tor-2 (Wallac Instruments, Turku, Finland), with the ex-
citation wavelength set at 385 nm and an emission wave-
length of 505 nm. The protein concentrations of the
respective samples were measured with a commercially
available kit (Pierce Assay; Pierce, Cramlington, United
Kingdom), and caspase-3–like activity was calculated as
microunits per milligram protein with 1 U/mg being
equal to the cleavage of 1 pmol 7-amino-4-triflurometh-
ylcoumarin per milligram protein and minute.
In addition, caspase-3 activation in Jurkat cells was
measured by Western blot. Equal amounts of whole cell
lysate (5 l/lane, corresponding to 5  105 cells) were
separated by sodium dodecyl sulfate polyacrylamide gel
electrophoresis in 10% polyacrylamide gels in a Mini
Protean II chamber (BioRad, Hercules, CA). Proteins
were subsequently electrotransferred onto a nylon mem-
brane (Immobilon P; Millipore, Bedford, MA), and mem-
branes were blocked overnight at 4°C in tris-buffered
saline supplemented with 0.1% Tween-20 and 0.2% bo-
vine serum albumin (Sigma). Caspase-3 protein was de-
tected using a specific antibody against caspase-3 from
Santa Cruz (Santa Cruz, CA) and a peroxidase coupled
secondary antibody (Dako, Glostrup, Denmark). Specific
binding was visualized by enhanced chemiluminescence
(Amersham, Buckinghamshire, United Kingdom) on x-
ray film (Kodak, Rochester, NY) following the manufac-
turer’s recommendations. The molecular weight of the
protein bands were determined by use of prestained
low-molecular-weight markers (Sigma) on the same gel.
Statistics
Data are given as mean  SD. The dose-dependent
effect of thiopental was analyzed by one-way analysis of
variance and post hoc testing (Tukey); in other experi-
ments, mean values were compared using the Student
two-tailed t test for independent means or the Mann–
Whitney U test. Differences were regarded as significant
if P was less than 0.05.
Results
Thiopental Dose-dependently Induces Cell Death in
Human Lymphocytes
Thiopental in concentrations from 5 to 500 g/ml
dose-dependently increased apoptosis and necrosis in
isolated human lymphocytes (106 cells/ml). The propor-
tion of necrotic (Annexin-V–positive, PI-positive) cells
was higher than that of apoptotic (Annexin-V–positive,
PI-negative) cells. Apoptosis increased only marginally,
whereas necrosis increased from 3.0  1.3% up to
38.1  16.9% after 24 h and up to 48.4  19.9% after
48 h (fig. 1). Analysis of variance (P 0.05) and post hoc
tests (Tukey) revealed significant differences of necrotic
cells at thiopental concentrations above 250 g/ml (P 
0.05) compared with medium alone.
Effect of Thiopental on Apoptosis of Jurkat Cells
Spontaneous apoptosis (Annexin-V positive, PI nega-
tive) of cultured Jurkat cells (106 cells/ml) was 4.4 
1.9% after 24 h and 6.1  2.0% after 48 h (fig. 2),
whereas 3.0  1.0 and 4.0  1.0% necrotic (Annexin-
V–positive, PI-positive) cells were detected after 24 and
48 h, respectively (fig. 2). Incubation with 5–500 g/ml
thiopental dose-dependently increased apoptosis up to
29.7  2.8% after 24 h and 39.7  3.2% after 48 h and
secondary necrosis up to 21 and 29%, respectively (fig.
2). In contrast to lymphocytes, Jurkat cells exhibited a
lower proportion of secondary necrotic (Annexin-V–pos-
itive, PI-positive) cells compared with apoptotic (An-
nexin-V–positive, PI-negative) cells. The amount of pure
necrotic (Annexin-V–negative, PI-positive) cells was
1.7  2.3% after 24 h and 2.0  2.0% after 48 h and was
independent of thiopental treatment.
Thiopental-induced apoptosis was also seen in cyto-
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spin slides stained by the TUNEL method. Here, the
percent of TUNEL-positive cells after 24 h in freshly
isolated lymphocytes and Jurkat cells (3.2  2.6 and
5.5  3.2%, respectively) increased dose dependently
after incubation with thiopental up to 17.7  4.9 and
20.1  8.2%, respectively (table 1).
Expression of CD95 after Thiopental Treatment in
Jurkat Cells
To investigate whether thiopental-induced apoptosis
was mediated through CD95 expression and subsequent
autocrine and/or paracrine induction of cell death, ex-
pression of CD95 on Jurkat cells was measured in FACS
after incubation with thiopental (5–500 g/ml). How-
ever, expression of CD95 on the cell surface of Jurkat
cells (6.9  0.6 mean fluorescence) was not altered
significantly 4 h after incubation with 250 g/ml thio-
pental (8.6  0.9 mean fluorescence) (table 2). To
further test whether the CD95 system is involved in
thiopental-induced apoptosis, Jurkat cells were preincu-
bated with an antagonistic anti-CD95 (SM 1/23) antibody
(500 ng/ml) before stimulation with thiopental (250 g/
ml) or an agonistic anti-CD95 (CH11) antibody (100
ng/ml). Anti-CD95 induced apoptosis (16.7  0.4%)
could be completely blocked (9.7  2.8%) similar to
necrosis (60.0  7.0 vs. 5.1  3.3%, respectively) by
Fig. 1. Thiopental induces apoptosis in human lymphocytes.
Isolated cells (1  106/ml) were stained with fluorescein iso-
thiocyanate–Annexin-V and propidium iodine after incubation
with increasing concentrations of thiopental (5–500 g/ml) for
24 h (black bars) or 48 h (gray bars). Data are reported as the
percentage of apoptotic (Annexin-V–positive, propidium io-
dine–negative) cells (A) or secondary necrotic (Annexin-V–pos-
itive, propidium iodine–positive) cells (B). Results represent the
mean  SD of eight separate experiments. Analysis of variance
(Tukey test): * P < 0.05 with versus without thiopental.
Fig. 2. Thiopental induces apoptosis and secondary necrosis of
Jurkat cells. Cells (1  106/ml) were stained with fluorescein
isothiocyanate–Annexin-V and propidium iodine after incuba-
tion with increasing concentrations of thiopental (5–500 g/
ml) for 24 h (black bars) or 48 h (gray bars). Data are reported
as the percentage of apoptotic (Annexin-V–positive, propidium
iodine–negative) cells (A) or secondary necrotic (Annexin-V–
positive, propidium iodine–positive) cells (B). Results represent
the mean  SD of eight separate experiments. Analysis of vari-
ance (Tukey test): * P < 0.05 with versus without thiopental.
Table 1. Incubation with Thiopental and TUNEL Staining of
Lymphocytes and Jurkat Cells
Lymphocytes Jurkat Cells
Thiopental, g/ml — — z-VAD-fmk
0 3.2  2.6 5.5  3.2 4.8  2.4
5 4.2  3.1 6.9  2.1 ND
50 4.9  2.7 10.2  4.1 ND
100 6.5  4.0 12.8  3.9 ND
250 11.4  3.8* 15.1  3.7* 6.8  2.0†
500 17.7  4.9* 20.1  8.2* ND
CD95 4.5  2.3 41.8  0.4 6.9  3.2†
Lymphocytes (1 106/ml) were stimulated with or without thiopental for 24 h and
apoptosis determined by terminal deoxynucleotidyl transferase–mediated dUTP
nick end labeling (TUNEL) staining. Jurkat cells (1  106/ml) were preincubated
1 h with or without z-VAD-fmk (20 M) before stimulation with or without thio-
pental for 24 h. Data is given in percent of TUNEL-positive cells. Data are from
five independent experiments and are presented as mean  SD.
Analysis of variance (Tukey test): * P  0.05 thiopental vs. medium; † P  0.05
z-VAD-fmk vs. medium.
ND  not determined.
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preincubation with antagonistic anti-CD95 antibody (SM
1/23), whereas no effect was observed in thiopental-
induced apoptosis (15.3  0.7 vs. 16.0  0.6%, respec-
tively) or necrosis (37.8 13.1 vs. 38.2 10.0%) (fig. 3).
This indicates that thiopental-induced apoptosis and ne-
crosis is independent of the CD95 system.
Effect of Thiopental on Caspase-3–like Activity
To test whether caspase-3 was involved in thiopental-
induced apoptosis, caspase-3–like activity was measured
in Jurkat cells after incubation with increasing doses of
thiopental (5–500 g/ml). Thiopental dose-dependently
and in parallel to apoptosis significantly (P  0.05)
increased caspase-3–like activity from basal level (88.0
14.4 U) to 364.0  95.1 U after incubation with 500
g/ml thiopental for 24 h (fig. 4). The activation of
caspase-3 was confirmed in Western blot. Whole cell
lysates from Jurkat cells incubated for 24 h with medium
or thiopental (5–500 g/ml) were separated by electro-
phoresis and Western blot stained with caspase-3–spe-
cific antibodies. Activation of caspase-3 is characterized
by a reduction of the pro–caspase-3 band. As depicted in
figure 5, thiopental dose-dependently reduces pro–
caspase-3 band, indicating activation of caspase-3 by
thiopental (fig. 5). Densitometric analysis of Western
blots where the medium control was set at 100% yielded
values for incubation with 5, 50, 100, 250, and 500
Table 2. Effect of Thiopental on CD95 Expression on Jurkat
Cells
Thiopental, g/ml Mean Fluorescence
0 6.9  1.4
5 6.9  1.3
50 7.3  1.6
250 8.6  2.0
500 9.5  1.2
Jurkat cells (1  106/ml) were treated with or without thiopental for 24 h.
Expression of CD95 on the cell surface was detected by phycoerythrin-
labeled anti-human CD95 antibody. Data are from three independent exper-
iments and are presented as mean  SD.
Fig. 3. Thiopental is independent of CD95-induced apoptosis.
Jurkat cells (1  106/ml) were preincubated with (shaded bars)
or without (white bars) an inhibitory anti-CD95 antibody (SM1/
23; 500 ng/ml) 1 h before stimulation with thiopental (250
g/ml) and/or an agonistic anti-CD95 antibody (CH11; 100 ng/
ml) for 24 h. Data are reported as the percentage of apoptotic
(Annexin-V–positive, propidium iodine–negative) cells (A) or
secondary necrotic (Annexin-V–positive, propidium iodine–
positive) cells (B). Results represent the mean  SD of five
separate experiments. Student t test: * P < 0.05 with versus
without thiopental; † P < 0.05 with versus without anti-CD95; #
P < 0.05 with versus without SM1/23.
Fig. 4. Caspase-3 activation in Jurkat cells by thiopental. Jurkat
cells (1  106/ml) were incubated with increasing concentra-
tions of thiopental (5–500 g/ml) for 24 h, and caspase-3 activ-
ity was measured in the cell lysate by DEVD-afc cleavage. Results
represent the mean SD of five separate experiments. Analysis
of variance (Tukey test): * P < 0.05 with versus without thio-
pental.
Fig. 5. Decrease of pro–caspase-3 in Jurkat cells by thiopental.
Jurkat cells (1  106/ml) were incubated with increasing con-
centrations of thiopental (5–500 g/ml) for 24 h and the de-
crease of pro–caspase-3 (determined by molecular size) de-
tected in Western blot after electrophoresis. Equal protein,
corresponding to 5  105 cells, of whole cell lysate was sepa-
rated by sodium dodecyl sulfate polyacrylamide gel electro-
phoresis on a 10% gel and immunostained with a caspase-3
antibody and respective horseradishperoxydase-labeled sec-
ondary antibodies and visualized by enhanced chemilumines-
cence. One of five separate experiments shown. The amount of
pro–caspase-3 protein was quantified by densitometry, and the
relative density of bands is given as mean  SD (%) from the
medium-only treated cells value (set at 100%) of the five West-
ern blots.
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g/ml thiopental of 97.5  9.6, 94.6  11.7, 81.2 
18.6, 64.1  24.3, and 65.1  21.5%, respectively. Val-
ues were derived from five separate Western blots.
Inhibition of Caspases and Thiopental-induced
Apoptosis
The involvement of caspase-3 was further studied by
preincubating Jurkat cells (106 cells/ml) and human lym-
phocytes (106 cells/ml) with the pan-caspase inhibitor
z-VAD-fmk (20 M), and apoptosis was measured after 24
and 48 h. Thiopental (250 g/ml)–induced apoptosis
after 24 h of Jurkat cells (20.2  2.5%) was reduced only
insignificantly by z-VAD-fmk (17.2  2.5%), whereas
secondary necrosis (17.0  3.0%) was significantly re-
duced (6.6  1.2%) (fig. 6). In contrast, CD95-induced
apoptosis (27.0  2.0%) was completely (P  0.05)
blocked (8.1 1.8%). These result are also supported by
TUNEL-stained cells (table 1) showing a reduction of
thiopental-stimulated TUNEL-positive cells (15.1 3.7%)
after preincubation with z-VAD-fmk (6.8  2.0%).
Similar results were seen after 48 h in Jurkat cells (fig.
6). In isolated lymphocytes, no effect of z-VAD-fmk was
seen on thiopental-induced apoptosis and necrosis after
24 and 48 h (fig. 7).
CD95-induced caspase-3–like activity (551.0  56.9
U), as well as thiopental (250 g/ml)–induced activity
(232.0  33.6 U) in Jurkat cells after 24 h was com-
pletely blocked by z-VAD-fmk (7.0  3.0 and 8.5  3.6
U, respectively) (fig. 8), confirming the effectiveness of
z-VAD-fmk.
Activation of Mitochondrial Apoptosis by
Thiopental
It has been shown that thiopental leads to activation of
mitochondria.31 Therefore, Jurkat cells (106 cells/ml)
were incubated with increasing doses of thiopental (5–
500 g/ml) for 24 and 48 h, and cells were stained
afterward with rhodamine 123 for detection of mito-
chondrial membrane breakdown. The mitochondrial
membrane breakdown is represented by a shift of mean
fluorescence (decrease in channel number) in the cells.
Fig. 6. Effect of a broad caspase inhibitor z-VAD-fmk on thio-
pental and/or CD95-induced apoptosis. Jurkat cells (1 106/ml)
were incubated with thiopental (250 g/ml) and/or anti-CD95
antibody (CH11; 100 ng/ml) for 24 h (black bars) or 48 h (gray
bars) after pretreatment of 1 h with or without z-VAD-fmk (20
M). The cells were stained with fluorescein isothiocyanate–
Annexin-V and propidium iodine and analyzed in flow cytom-
etry. Data are reported as the percentage of apoptotic (Annexin-
V–positive, propidium iodine–negative) cells (A) or secondary
necrotic (Annexin-V–positive, propidium iodine–positive) cells
(B). Results represent the mean  SD of seven separate exper-
iments. Student t test: * P < 0.05 with versus without thiopental
or anti-CD95; # P < 0.05 with versus without z-VAD-fmk.
Fig. 7. Effect of a broad caspase inhibitor z-VAD-fmk on thio-
pental and/or CD95-induced apoptosis. Human lymphocytes (1
 106/ml) were incubated with thiopental (250 g/ml) and/or
anti-CD95 antibody (CH11; 100 ng/ml) for 24 h (black bars) or
48 h (gray bars) after pretreatment of 1 h with or without
z-VAD-fmk (20 M). The cells were stained with fluorescein
isothiocyanate–Annexin-V and propidium iodine and analyzed
in flow cytometry. Data are reported as the percentage of apo-
ptotic (Annexin-V–positive, propidium iodine–negative) cells
(A) or secondary necrotic (Annexin-V–positive, propidium io-
dine–positive) cells (B). Results represent the mean  SD of
seven separate experiments. Mann–Whitney U test: * P < 0.05
with versus without thiopental.
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Parallel to apoptosis, thiopental dose-dependently in-
creased the amount of rhodamine-shifted cells (13.9 
3.9 to 60.2 10.9%) after 24 and 48 h (82.6 13.4%) of
all cells counted (fig. 9). Incubation with agonistic CD95
antibody increased rhodamine-negative cells to 94.1 
2.7% after 24 h and 99.0  0.4% after 48 h (data not
shown).
Inhibition of NF-B and Thiopental-induced
Apoptosis
Recently, activation of NF-B by thiopental has been
shown in Jurkat cells. Therefore, gliotoxin, a specific
inhibitor of NF-B, was used as a pharmacologic tool to
investigate the involvement of NF-B in the regulation of
thiopental-induced apoptosis. Because of the high rate of
cell death after incubation with agonistic CD95 anti-
body, after 24 h, the concentration of agonistic CD95
antibody was decreased from 100 ng/ml to 20 ng/ml,
and the incubation time was reduced to 16 h in this
experiment. Jurkat cells (106 cells/ml) were incubated
for 16 h with increasing doses of gliotoxin (0.001–0.01
g/ml) in presence or absence of thiopental (250 g/l)
or agonistic CD95 antibody (20 ng/ml). Gliotoxin dose-
dependently increased the proapoptotic effect of thio-
pental from 29.9  3.6 to 72.7  6.5% cell death (apo-
ptosis and secondary necrosis; fig. 10) and in the highest
concentration (0.01 g/ml) induced cell death (54.9 
12.2 vs. 13.1  2.7%) by itself, indicating that NF-B
activity is necessary for survival of Jurkat cells. Even
CD95-induced cell death after 16 h (65.9  6.7%) was
further increased by 0.01 g/ml gliotoxin (86.8 6.2%),
indicating that NF-B activation is also necessary in
CD95-induced apoptosis (fig. 10).
Discussion
In patients with severe traumatic brain injury, the
barbiturate coma can be the final resort in the therapy of
Fig. 8. Inhibition of thiopental and anti-CD95-induced caspase-3
activation by z-VAD-fmk. Jurkat cells (1  106/ml) were incu-
bated with thiopental (250 g/ml) and/or anti-CD95 antibody
(CH11; 100 ng/ml) for 24 h after pretreatment with (gray bars)
or without (black bars) the pan-caspase inhibitor z-VAD-fmk
(20 M). Caspase-3 activity was measured by DEVD-afc cleavage.
Results represent the mean  SD of five separate experiments.
Student t test: * P < 0.05 with versus without thiopental; § P <
0.05 with versus without anti-CD95; # P < 0.05 with versus
without z-VAD-fmk.
Fig. 9. Thiopental induces mitochondrial apoptosis in Jurkat
cells. Jurkats (1  106/ml) were stained with rhodamine 123
after incubation with increasing concentrations of thiopental
(5–500 g/ml) for 24 h (black bars) or 48 h (gray bars). Apo-
ptotic cells are represented by a shift of mean fluorescence to
the left. Data are given as percent of shifted cells from all cells
measured. Results represent the mean  SD of five separate
experiments. Analysis of variance (Tukey test): * P < 0.05 with
versus without thiopental.
Fig. 10. Gliotoxin enhances thiopental and CD95-induced cell
death. Jurkat cells (1  106/ml) were incubated with thiopental
(250 g/ml) and/or anti-CD95 antibody (CH11; 20 ng/ml) for
16 h after pretreatment with medium (black bars) or 0.001
g/ml (light gray bars) and 0.01 g/ml (dark gray bars) glio-
toxin. The cells were stained with fluorescein isothiocyanate–
Annexin-V and propidium iodine and analyzed in flow cytom-
etry. Data are reported as the sum of apoptotic (Annexin-V–
positive, propidium iodine–negative) and secondary necrotic
(Annexin-V–positive, propidium iodine–positive) cells. Results
represent the mean  SD of five separate experiments. Student
t test: * P < 0.05 with versus without thiopental or anti-CD95; #
P < 0.05 with versus without gliotoxin.
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life-threatening increases of the ICP, whenever other
therapeutic regimens do not reduce ICP.7 However, this
therapy is often complicated by disturbed immunocom-
petence with leukopenia and an increased infection
rate.10–12 It could be speculated that thiopental would
have proapoptotic activity on immune cells. This sugges-
tion is supported by the observation that intravenous
administration of barbiturate depresses lymphocyte acti-
vation.14
The presented results demonstrate the proapoptotic
activity of thiopental on Jurkat T cells and human lym-
phocytes. In previous studies, drug-induced apoptosis of
immune cells was focused on cancer therapy.21,32,33
Villunger et al.21 showed that drug-induced apoptosis is
associated with enhanced CD95 ligand expression but
occurs independently of CD95 signaling in human acute
lymphatic leukemia T cells. In contrast, Krammer and
coworkers postulated CD95/CD95 ligand signaling as
the central effector pathway of drug-induced apopto-
sis.34,35 Although thiopental enhanced the CD95-in-
duced apoptosis in Jurkat cells, the facts that thiopental
did not alter CD95 expression on Jurkat cells and thio-
pental-induced Jurkat cell apoptosis could not be pre-
vented by pretreatment with antagonistic anti-CD95 an-
tibody points to a CD95-independent pathway of
thiopental-induced lymphocyte apoptosis.
In a recent study, it was shown that opioids, com-
monly used as potent analgesics, induced CD95 expres-
sion on human lymphocytes and promoted CD95-medi-
ated apoptosis.36,37 This effect was blocked by
naloxone, an antagonist of the opioid receptors, which
are also expressed on lymphocytes.32 In the same line,
Yin et al.33 showed that stress modulates the immune
system with an increase of T-cell apoptosis through
CD95-mediated apoptosis dependent on endogenous
opioids. These data were in accord with previous results
from Oka et al.38 who demonstrated that circulating
lymphocytes in the early perioperative period are sus-
ceptible to CD95-mediated apoptosis, which may cause
depletions of circulating lymphocytes after surgery.
However, in the current study, no influence of naloxone
was observed on the thiopental-induced apoptosis (data
not shown). Therefore, in contrast to opioids, thiopental
acts via a different mechanism.
The observation that caspase-3 activity increased in
parallel to apoptotic rate after incubation with thiopen-
tal suggested a pivotal role of caspase-3 in thiopental-
induced apoptosis. However, the pretreatment with the
pan-caspase-inhibitor z-VAD-fmk did not completely in-
hibit the apoptotic effect by thiopental, whereas the
anti-CD95–induced apoptosis was completely blocked
by z-VAD-fmk. The current dogma that caspase activity is
essential for execution of apoptosis has been under
scrutiny recently,24,30 because certain apoptotic charac-
teristics such as cell shrinkage, membrane blebbing, and
nuclear condensation were found to be insensitive to-
ward caspase inhibitors.39 This is confirmed through the
results of this study that effective inhibition of the com-
plete caspase cascade through the pan-caspase inhibitor
z-VAD-fmk did not completely reduce thiopental-in-
duced Jurkat cell apoptosis and lymphocyte necrosis.
This caspase independence and the differences seen
between Jurkat cells and freshly isolated lymphocytes in
the mode of cell death and induction of necrosis in our
experiments have been described before.40 Therefore,
our results indicate that further factors must be involved
in the regulation and execution of thiopental-induced
cell death, i.e., apoptosis and necrosis. Today, apoptosis
and necrosis are seen as the two extremes of a wide
spectrum of cell demise including caspase-independent
cell death, with a multitude of factors involved.24
Recently other proteases, namely calpains,13,41 cathe-
psins,42,43 or the proteasome44 have been discussed as
alternative factors of cellular apoptosis. As further alter-
native concept of apoptotic execution, a loss in mito-
chondrial membrane barrier function is discussed in the
literature.15 This is supported by recent findings show-
ing an exaggerated generation of oxygen radicals after
incubation with 20 mmol/ml thiopental.31 This in-
creased production of oxygen radicals by thiopental
could enhance lymphocyte commitment to apoptosis
and is also in accord with our observation of decreased
rhodamine staining after thiopental incubation. How-
ever, further investigations are necessary to clarify this
mechanism.
Recently, it has been shown that thiopental inhibits
activation of NF-B in lymphocytes and Jurkat cells25 via
inhibition of the calmodulin–calcineurin complex path-
way.45 We could confirm these findings by gliotoxin
inhibition of NF-B, which enhanced the spontaneous
apoptosis and the proapoptotic effect of thiopental in
Jurkat cells. This shows that NF-B plays a central role
not only in regulation of drug-induced apoptosis but also
in the survival of lymphocytes during homeostasis, pos-
sibly by transcription of survival genes. It has been
shown in another study that NF-B controls the tran-
scriptional activity of a gene, which induces the synthe-
sis of survival proteins.46 Furthermore, in a number of
immune cells, NF-B activation has been shown to play
a pivotal role in regulating the genes for inflammatory
cytokines, which inhibit the apoptotic process, probably
by activation of NF-B in a positive-feedback loop.46
Recently, Humar et al.47 showed that thiopental and
other barbiturates indirectly suppress the activation of
the transcription factor activator protein 1. However, in
contrast to other closely related barbiturates, thiopental
does not act through activation of mitogen-activated
protein kinases and small G proteins, but through other
mechanisms.47
In conclusion, we could show that thiopental acts as
an apoptosis-inducing agent for lymphocytes and,
through this, might contribute to the severe immuno-
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suppression during thiopental coma in patients with
traumatic brain injury. We are aware of the preliminary
nature of our observations, and the exact mechanisms of
thiopental-induced cell death in lymphocytes need fur-
ther investigation. Elucidating the mechanism of thio-
pental-induced cell death might help to improve thio-
pental therapy and prevent lymphocyte apoptosis and
risk of nosocomial infections in thiopental-treated pa-
tients.
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